CDC42BPG

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, CDC42BPG RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated CDC42BPG data layer compared with 10 for mutation status and 5 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CDC42BPG RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CDC42BPG expression acts as an unfavorable survival marker, although some lineages such as KIRP and KIRC show a favorable association.

KIRP, KIRC, and UVM are the cancer types where CDC42BPG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRPDFSMedianAll0.9730.846<.001121view →
KIRCOSMedianAll0.7280.542<.001106view →
UVMDFSMedianAll0.7360.423<.00198view →
LGGDFSMedianAll0.6140.846<.00154view →
SKCMOSMedianAll0.7240.840<.00149view →
SCLCDFSMedianII,III,IV0.8190.205.00430view →
BRCADFSTertileIV0.3700.873.00129view →
ACCOSTertileIII,IV0.9190.324.01315view →
LUSCDFSQuartileIII,IV0.3790.935.01412view →
OVOSMedianIII,IV0.2700.375.0098view →
THYMDFSMedianIII,IV0.9120.436.0426view →
BLCAOSQuartileAll0.8060.671.0246view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

CDC42BPG–KIRP (DFS)

Kaplan–Meier survival curve for CDC42BPG RNA-high vs -low samples in KIRP.

Open the KIRP breakdown →

Exploration